Qureight
Qureight’s mission is to advance the understanding of lung and heart disease. It does this through its proprietary AI and image curation platform which allows it to manage images during a clinical trial, provide rapid central scan review and create novel placebo synthetic arms. Its current main areas of focus are IPF, PPF, CTD-ILD and Pulmonary Hypertension. The company is based in Cambridge UK and is led by clinicians, radiologists and data science experts.
